Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

estradiol-norethindrone

estradiol-norethindrone
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Combipatch FILM, EXTENDED RELEASE, TRANSDERMAL 0.05 mg-0.14 mg/24 hours      
Combipatch FILM, EXTENDED RELEASE, TRANSDERMAL 0.05 mg-0.25 mg/24 hours    
Activella, Mimvey TABLET, ORAL 0.5 mg-0.1 mg, 1 mg-0.5 mg      
VIEW MORE Estrogens
CLASS
681604
Comments:

ORDERED FORMULATION

THERAPEUTIC INTERCHANGE

estradiol-norethindrone (Combipatch)

  • 0.05 mg-0.25 mg/24 hours extended release film transdermal twice weekly

estradiol-norethindrone (Combipatch)

  • 0.05 mg-0.14 mg/24 hours extended release film transdermal twice weekly

 Activella is restricted to use other than for contraception.

Reviewed: 27 March 2018

Last updated: Jun. 29, 2022






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2024 Rpharmy, LLC ­ All Rights Reserved